Works matching IS 02704137 AND DT 2015 AND VI 75 AND IP 15


Results: 15
    1
    2

    DNA methylation screening of primary prostate tumors identifies SRD5A2 and CYP11A1 as candidate markers for assessing risk of biochemical recurrence.

    Published in:
    Prostate, 2015, v. 75, n. 15, p. 1790, doi. 10.1002/pros.23052
    By:
    • Horning, Aaron M.;
    • Awe, Julius A.;
    • Wang, Chiou ‐ Miin;
    • Liu, Joseph;
    • Lai, Zhao;
    • Wang, Vickie Yao;
    • Jadhav, Rohit R.;
    • Louie, Anna D.;
    • Lin, Chun ‐ Lin;
    • Kroczak, Tad;
    • Chen, Yidong;
    • Jin, Victor X.;
    • Abboud ‐ Werner, Sherry L.;
    • Leach, Robin J.;
    • Hernandez, Javior;
    • Thompson, Ian M.;
    • Saranchuk, Jeff;
    • Drachenberg, Darrel;
    • Chen, Chun ‐ Liang;
    • Mai, Sabine
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    ABO blood group alleles and prostate cancer risk: Results from the breast and prostate cancer cohort consortium (BPC3).

    Published in:
    Prostate, 2015, v. 75, n. 15, p. 1677, doi. 10.1002/pros.23035
    By:
    • Markt, Sarah C.;
    • Shui, Irene M.;
    • Unger, Robert H.;
    • Urun, Yuksel;
    • Berg, Christine D.;
    • Black, Amanda;
    • Brennan, Paul;
    • Bueno ‐ de ‐ Mesquita, H. Bas;
    • Gapstur, Susan M.;
    • Giovannucci, Edward;
    • Haiman, Christopher;
    • Henderson, Brian;
    • Hoover, Robert N.;
    • Hunter, David J.;
    • Key, Timothy J.;
    • Khaw, Kay ‐ Tee;
    • Canzian, Federico;
    • Larranga, Nerea;
    • Le Marchand, Loic;
    • Ma, Jing
    Publication type:
    Article